JP2018527333A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527333A5 JP2018527333A5 JP2018504932A JP2018504932A JP2018527333A5 JP 2018527333 A5 JP2018527333 A5 JP 2018527333A5 JP 2018504932 A JP2018504932 A JP 2018504932A JP 2018504932 A JP2018504932 A JP 2018504932A JP 2018527333 A5 JP2018527333 A5 JP 2018527333A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- mospd2
- composition according
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562199571P | 2015-07-31 | 2015-07-31 | |
| US62/199,571 | 2015-07-31 | ||
| PCT/IB2016/054584 WO2017021857A1 (en) | 2015-07-31 | 2016-07-29 | Motile sperm domain containing protein 2 and cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018527333A JP2018527333A (ja) | 2018-09-20 |
| JP2018527333A5 true JP2018527333A5 (https=) | 2020-04-23 |
| JP6949818B2 JP6949818B2 (ja) | 2021-10-13 |
Family
ID=57942495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504932A Active JP6949818B2 (ja) | 2015-07-31 | 2016-07-29 | 運動精子ドメイン含有タンパク質２及びがん |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190040150A1 (https=) |
| EP (2) | EP3735977A1 (https=) |
| JP (1) | JP6949818B2 (https=) |
| CN (1) | CN108135933B (https=) |
| AU (1) | AU2016303474B2 (https=) |
| CA (1) | CA2991868C (https=) |
| ES (1) | ES2839456T3 (https=) |
| IL (1) | IL257260B (https=) |
| NZ (1) | NZ738875A (https=) |
| WO (1) | WO2017021857A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2991868C (en) | 2015-07-31 | 2025-05-27 | Immunewalk Therapeutics, Inc. | PROTEIN 2 CONTAINING THE MOTILE SPERM DOMAIN AND CANCER |
| EP3328408B1 (en) * | 2015-07-31 | 2020-10-07 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 and inflammation |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| JP2021517153A (ja) * | 2018-03-13 | 2021-07-15 | バスキュラー バイオジェニックス リミテッド | Ｍｏｓｐｄ２およびｔ細胞またはｎｋ細胞特異的分子に対する二重特異性抗体 電子出願された配列表の参照 |
| EP3597193A1 (en) * | 2018-07-16 | 2020-01-22 | Universitat Autònoma de Barcelona | Therapeutic use of afatinib in cancer |
| WO2022053985A1 (en) | 2020-09-10 | 2022-03-17 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 antibodies and methods of use thereof |
| US20250277052A1 (en) * | 2021-03-29 | 2025-09-04 | Immunewalk Therapeutics, Inc. | Motile sperm domain containing protein 2, integrin beta2 and cd63 |
| USD1105906S1 (en) * | 2023-11-29 | 2025-12-16 | Ufp Industries, Inc. | Removable clip |
| USD1106811S1 (en) * | 2023-11-29 | 2025-12-23 | Ufp Industries, Inc. | Removable clip |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE922437A1 (en) | 1991-07-25 | 1993-01-27 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| JP3597140B2 (ja) | 2000-05-18 | 2004-12-02 | 日本たばこ産業株式会社 | 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途 |
| EP1414963A2 (en) * | 2000-12-08 | 2004-05-06 | Incyte Genomics, Inc. | Lipid-associated molecules |
| CA2437497A1 (en) * | 2001-02-06 | 2002-08-15 | Incyte Genomics, Inc. | Lipid-associated molecules |
| US20040171009A1 (en) * | 2001-05-18 | 2004-09-02 | Tang Y. Tom | Lipid-associated molecules |
| CA2447647A1 (en) * | 2001-05-18 | 2002-11-28 | Incyte Genomics, Inc. | Lipid-associated molecules |
| AU2002334632A1 (en) * | 2001-09-21 | 2003-04-01 | Incyte Genomics, Inc. | Lipid-associated molecules |
| EP1463487B1 (en) * | 2001-12-19 | 2010-05-19 | Research Development Foundation | Liposomal delivery of vitamin e based compounds |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| US20090137687A1 (en) * | 2003-02-28 | 2009-05-28 | Oxigene, Inc. | Compositions and Methods With Enhanced Therapeutic Activity |
| JP4810642B2 (ja) * | 2004-11-30 | 2011-11-09 | 秋田県 | 癌転移抑制用トリテルペン誘導体及び該トリテルペン誘導体を用いた癌転移抑制用組成物 |
| US20070218116A1 (en) | 2006-03-14 | 2007-09-20 | Schwendener Reto A | Compositions and methods for the treatment of tumors and tumor metastases |
| WO2010042228A2 (en) * | 2008-10-10 | 2010-04-15 | Cornell University | Methods for predicting disease outcome in patients with colon cancer |
| CN102271517B (zh) | 2008-11-06 | 2015-04-08 | 脉管生物生长有限公司 | 氧化的脂质化合物和其用途 |
| WO2010113096A1 (en) | 2009-03-30 | 2010-10-07 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Methods of predicting clinical course and treating multiple sclerosis |
| JP2012529914A (ja) | 2009-06-15 | 2012-11-29 | カーディオ ディーエクス インコーポレイティッド | 冠動脈疾患リスクの判定法 |
| WO2011159951A2 (en) | 2010-06-17 | 2011-12-22 | Sanford-Burnham Medical Research Institute | Targeting tumor associated macrophages using bisphosphonate-loaded particles |
| EP2420228A1 (en) * | 2010-08-05 | 2012-02-22 | Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG | Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer |
| DE102011005235B4 (de) | 2011-03-08 | 2017-05-24 | Sirs-Lab Gmbh | Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten |
| WO2012121679A1 (en) * | 2011-03-09 | 2012-09-13 | Agency For Science, Technology And Research | Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage |
| CN104066706B (zh) * | 2011-12-12 | 2017-12-19 | 脉管生物生长有限公司 | 炎症的治疗 |
| CN103592432B (zh) * | 2013-10-15 | 2015-06-03 | 重庆市公安局 | 一种免疫磁珠分离精子与上皮细胞混合斑中精子的方法 |
| EP3328408B1 (en) | 2015-07-31 | 2020-10-07 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 and inflammation |
| CA2991868C (en) | 2015-07-31 | 2025-05-27 | Immunewalk Therapeutics, Inc. | PROTEIN 2 CONTAINING THE MOTILE SPERM DOMAIN AND CANCER |
| WO2022053985A1 (en) | 2020-09-10 | 2022-03-17 | Vascular Biogenics Ltd. | Motile sperm domain containing protein 2 antibodies and methods of use thereof |
| US20250277052A1 (en) | 2021-03-29 | 2025-09-04 | Immunewalk Therapeutics, Inc. | Motile sperm domain containing protein 2, integrin beta2 and cd63 |
-
2016
- 2016-07-29 CA CA2991868A patent/CA2991868C/en active Active
- 2016-07-29 EP EP20173680.8A patent/EP3735977A1/en active Pending
- 2016-07-29 EP EP16832394.7A patent/EP3328401B1/en active Active
- 2016-07-29 JP JP2018504932A patent/JP6949818B2/ja active Active
- 2016-07-29 AU AU2016303474A patent/AU2016303474B2/en active Active
- 2016-07-29 NZ NZ738875A patent/NZ738875A/en unknown
- 2016-07-29 US US15/747,920 patent/US20190040150A1/en not_active Abandoned
- 2016-07-29 WO PCT/IB2016/054584 patent/WO2017021857A1/en not_active Ceased
- 2016-07-29 CN CN201680044577.XA patent/CN108135933B/zh active Active
- 2016-07-29 IL IL257260A patent/IL257260B/en unknown
- 2016-07-29 ES ES16832394T patent/ES2839456T3/es active Active
-
2020
- 2020-10-13 US US17/068,959 patent/US11945875B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527333A5 (https=) | ||
| AU2020201289B2 (en) | Carrier-antibody compositions and methods of making and using the same | |
| US20220211870A1 (en) | Paclitaxel-albumin-binding agent compositions and methods for using and making the same | |
| US11945875B2 (en) | Motile sperm domain containing protein 2 and cancer | |
| US10966923B2 (en) | Carrier-antibody compositions and methods of making and using the same | |
| EP2903610B1 (en) | Cancer treatments | |
| US20180235886A1 (en) | Carrier-binding agent compositions and methods of making and using the same | |
| JP2024513505A (ja) | 腫瘍を治療するための組成物及び方法 | |
| CA3233721A1 (en) | Methods of treating cancer and the pharmaceutical compositions thereof | |
| JP7579284B2 (ja) | セマフォリン４ｄ遮断（ｓｅｍａ４ｄ）とｄｃ１療法との併用療法 | |
| CN108883068B (zh) | 乳癌治疗 | |
| KR20220133996A (ko) | 암 및 암 전이를 치료하기 위한 병용 요법 | |
| JP2021517153A (ja) | Ｍｏｓｐｄ２およびｔ細胞またはｎｋ細胞特異的分子に対する二重特異性抗体 電子出願された配列表の参照 | |
| WO2016191703A2 (en) | Tumor deliverable iron and protein synthesis inhibitors as a new class of drugs for the diagnosis and treatment of cancer | |
| JPWO2019175806A5 (https=) | ||
| RU2801828C2 (ru) | Комбинированная терапия блокированием семафорина 4d (sema4d) и терапией дк1 | |
| HK40041339A (en) | Motile sperm domain containing protein 2 and cancer | |
| Zhou | Development and Evaluation of LSR-and CD276-Targeted Therapies for Triple-Negative Breast Cancer | |
| WO2024159105A1 (en) | Methods of treating cancer comprising administration of intratumoral dcs in combination with systemic igg monoclonal antibody | |
| TW202535465A (zh) | 抗cd147抗體與其他抗腫瘤劑之組合 | |
| JP2026514110A (ja) | がんの処置および予防のための組合せ | |
| Bien et al. | Liposomal irinotecan in the treatment of refractory pancreatic cancer | |
| Mao | Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia | |
| OA18218A (en) | Carrier-antibody compositions and methods of making and using the same | |
| HK1254515B (en) | Motile sperm domain containing protein 2 and cancer |